The RAGE of COPD

慢性阻塞性肺病的愤怒

基本信息

  • 批准号:
    8971959
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Abstract: Objective: To determine the pathogenic mechanisms of COPD and to define new ways to prevent or treat the disorder. Hypotheses: We propose a new paradigm for a central role of the receptor for advanced glycation end products (RAGE) and its ligands in the emphysema pathogenesis. We hypothesize that RAGE and its ligands through distinct signaling pathways that include NADPH oxidase(s) (Nox)-generated reactive oxygen species (ROS) activate key transcription factors including NF-B and EGR-1 to propagate the inflammation, apoptosis and lung destruction leading to emphysema. Background: Chronic obstructive pulmonary disease (COPD) is a devastating disorder characterized by chronic airflow limitation. It is among the most common discharge diagnoses from VA hospitals and will be the third leading cause of death worldwide by the year 2020. In part, due to the still poorly elucidated or undiscovered mechanisms causing COPD, treatment options are very limited. COPD is associated with chronic inflammation, apoptosis and emphysema. This proposal is aimed at defining the biochemical mechanisms for the inflammation, apoptosis and emphysema. Aims: Aim 1 will determine the ability of RAGE and its ligands to promote inflammation, apoptosis and lung destruction leading to the development of emphysema. It will test the hypothesis that advanced glycation end products (AGEs) or other ligands interact with RAGE to amplify the inflammatory response and apoptosis that mediate the lung destruction leading to the development of emphysema. Aim 2 will determine the role of signaling intermediates in RAGE-induced lung inflammation, apoptosis and destruction leading to the development of emphysema. It will test the hypothesis that RAGE and its ligands acting through Nox(s) and NF-B or Egr-1, cause synthesis and release of pro-inflammatory cytokines and additional RAGE ligands, which further perpetuate RAGE expression, inflammation, oxidative and/or proteinase stress and apoptosis with resulting lung destruction. Aim 3 will determine whether lung macrophage RAGE or alveolar epithelial cell RAGE is primarily responsible for propagating inflammation, apoptosis and lung destruction leading to the development of emphysema. These studies will take advantage of unique mouse models with mononuclear or alveolar epithelial cell specific deletion of RAGE to test the hypothesis that lung macrophage RAGE is the primary effector of RAGE-mediated inflammation and lung destruction. Research Design: We will study the expression of RAGE and its ligands during the development of emphysema using a model of cigarette smoke exposure to mice. Mutant mice exposed to cigarette smoke will be used to determine the importance of RAGE and specific signaling pathways in emphysema development. Studies in isolated cells exposed to cigarette smoke extract will complement those proposed in mouse models to aide in delineating signaling pathways. A particular focus will be the role(s) of RAGE expressed on lung macrophages and alveolar epithelium since these are the primary sources of RAGE expression in the lungs of cigarette smokers. Significance: Successful outcome of this proposal will transform basic understanding of the pathobiochemistry of emphysema by focusing on pathways currently only tangentially mentioned in discussions of the mechanisms for development of the disorder. It will impact our ability to prevent or reduce the enormous medical burden caused by cigarette smoking. Nowhere is the need for new approaches with clinical application more important in pulmonary diseases than in COPD.
描述(由申请人提供):

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
RAGE is a Critical Mediator of Pulmonary Oxidative Stress, Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke.
RAGE 是香烟烟雾引起的肺氧化应激、肺泡巨噬细胞激活和肺气肿的关键调节因子。
  • DOI:
    10.1038/s41598-018-36163-z
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Sanders,KarlA;Delker,DonA;Huecksteadt,Tom;Beck,Emily;Wuren,Tanna;Chen,Yuntian;Zhang,Yuxia;Hazel,MarkW;Hoidal,JohnR
  • 通讯作者:
    Hoidal,JohnR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John R Hoidal其他文献

Chronic Endurance Stress Induces Cardiac Remodeling in Aged Nrf2-Null Mice
  • DOI:
    10.1016/j.freeradbiomed.2012.10.433
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dinesh Devadoss;Sellamuthu S. Gounder;Sankaranarayanan Kannan;Naqser Abu-Rmaileh;Kevin S Whitehead;E. Dale Abel;John R Hoidal;Rajasekaran Namakkal-Soorappan
  • 通讯作者:
    Rajasekaran Namakkal-Soorappan
PSS252 - Ablation of Nrf2 Sensitizes Skeletal Muscle to Cardiotoxin Induced Oxidative Stress and Impairs Regeneration
  • DOI:
    10.1016/j.freeradbiomed.2013.10.675
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Naser Abu-Rmaileh;Sankarnarayanan Kannan;Jennifer Hong;Nancy Atieno;Christopher J Davidson;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan
  • 通讯作者:
    Rajasekaran Namakkal Soorappan
Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective
  • DOI:
    10.1007/s11912-020-00992-x
  • 发表时间:
    2021-01-01
  • 期刊:
  • 影响因子:
    5.000
  • 作者:
    Tapan K Mukherjee;Parth Malik;John R Hoidal
  • 通讯作者:
    John R Hoidal
PSS264 - Nrf2 Deficiency Promotes Apoptosis and Impairs Pax7/MyoD Lineage in Aging Skeletal Muscle
  • DOI:
    10.1016/j.freeradbiomed.2013.10.687
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sankarnarayanan Kannan;Christopher J Davidson;Naser Abu-Rmaileh;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan
  • 通讯作者:
    Rajasekaran Namakkal Soorappan

John R Hoidal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John R Hoidal', 18)}}的其他基金

The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8669718
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8544152
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8803306
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6796754
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
Nicotine Abuse /Smoking-Related Disease Susceptibility
尼古丁滥用/吸烟相关疾病的易感性
  • 批准号:
    6549070
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6471692
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    7098903
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6631428
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
尼古丁成瘾的遗传学和后果
  • 批准号:
    7111760
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
尼古丁成瘾的遗传学和后果
  • 批准号:
    6948503
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了